Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy

Journal:

Nature Communications

Published:

2026-05-15

DOI:

10.1038/s41467-026-71710-7

Affiliations:

12

Authors:

31

Go to article

Institutions	Authors	Share
University of Pennsylvania (Penn), United States of America (USA)	13.733333 13.733333	0.44
Hospital of the University of Pennsylvania, Penn, United States of America (USA)	11.033333 11.033333	0.36
Abramson Cancer Center, Penn, United States of America (USA)	4.200000	0.14
University of Milan (UNIMI), Italy	0.500000	0.02
Humanitas University, Italy	0.500000	0.02
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA)	0.500000	0.02
The Winship Cancer Institute of Emory University, United States of America (USA)	0.333333	0.01
Parker Institute for Cancer Immunotherapy, United States of America (USA)	0.200000	0.01

Interested in Oncology and Carcinogenesis?